Cytosorbents CorporationCTSONASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank87
3Y CAGR+2.2%
5Y CAGR-1.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+2.2%/yr
vs +14.4%/yr prior
5Y CAGR
-1.3%/yr
Recent acceleration
Acceleration
-12.2pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$36.98M+3.9%
2024$35.59M+14.5%
2023$31.08M-10.4%
2022$34.69M-13.5%
2021$40.11M+1.7%
2020$39.45M+73.3%
2019$22.77M+12.4%
2018$20.25M+51.3%
2017$13.38M+63.1%
2016$8.21M-